Johnson & Johnson MedTech (NYSE:JNJ) announced that Kurt Van den Bosch has been appointed as its CFO, group finance.
Van den Bosch will be a member of Johnson & Johnson’s global finance team, reporting to the company’s EVP and CFO Joe Wolk. Van den Bosch’s role includes providing financial leadership to the global Johnson & Johnson MedTech organization.
He most recently served as area VP of mid-sized markets for J&J MedTech EMEA, overseeing the EMEA business that included the markets of Austria, Belgium, Greece, Israel, Portugal, Switzerland, the Netherlands and Scandinavian countries.
Van den Bosch joined Johnson & Johnson’s Janssen Pharmaceuticals, Belgium, company in 1990 as part of its finance team and has held a range of roles with increasing responsibility since. Before joining J&J MedTech, he was CFO for Janssen EMEA from 2012 to 2014, before being appointed to the role of CFO for global surgery EMEA in 2014, then CFO for medical devices EMEA in 2015.
Van den Bosch replaces Flavia Pease, who left J&J Medtech to serve as CFO of Wilmington, Massachusetts-based Charles River Laboratories.
